Clinical Guidelines > Current Guidelines

Current Guidelines

Each full guideline is presented below, in alphabetical order, with a short non-technical summary alongside the main guideline. The non-technical summary is less detailed than the full guideline and if you are reading this because it is relevant to your own healthcare, please do discuss any concerns or questions with your healthcare professionals.

* Guidelines currently being revised

The process used by the British HIV Association to produce its UK national guidelines has been accredited by the National Institute for Health and Clinical Excellence (NICE). Accreditation (obtained in July 2012) is now valid until July 2022 and is retrospectively applicable to guidance produced using the processes described in the BHIVA Guideline Development Manual. All guidance produced following the accredited process is eligible to bear the Accreditation Mark.



The BHIVA guidelines for HIV-associated malignancies 2014 have been archived. Instead, more recent, evidence-based, pan-European guidelines are available.

Corticosteroids, cancer chemotherapy and biologics: opportunistic infection prophylaxis
See European AIDS Clinical Society (EACS) guidelines:

Kaposi’s sarcoma
See European Society of Medical Oncology (ESMO) guidelines:

(NB These are links to external guidelines for which BHIVA has no responsibility)


Opportunistic infection (OI)

The 2011 OI guidelines (Treatment of opportunistic infection in HIV-seropositive individuals 2011) are being updated and published chapter-by-chapter, using GRADE methodology. Each chapter will be available here when complete and will replace the corresponding chapter from the 2011 guidelines. A non-technical summary will accompany each chapter and a section on supporting patients to apply to the whole guideline is in preparation. UK-CAB (community) members are involved in the writing and/or proofreading of each chapter, and where not listed as authors are the UK-CAB members of the Guidelines Subcommittee.

Post-exposure prophylaxis (PEP)

Pre-exposure prophylaxis (PrEP)